2666 — Genertec Universal Medical Co Share Price
- HK$9.29bn
- HK$66.40bn
- CNY13.66bn
- 38
- 91
- 84
- 85
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 3.9 | ||
PEG Ratio (f) | 0.36 | ||
EPS Growth (f) | 12.04% | ||
Dividend Yield (f) | 7.51% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.46 | ||
Price to Tang. Book | 0.48 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0.64 | ||
EV to EBITDA | 19.3 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 5.11% | ||
Return on Equity | 11.22% | ||
Operating Margin | 21.45% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | CNYm | 8,521.24 | 9,914.27 | 12,073.17 | 13,650.2 | 13,663.49 | 15,073.5 | 12,331.64 | 14.92% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +10.73 | -4.71 | -8.76 | +6.54 | +1.66 | +15.36 | +5.86 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Genertec Universal Medical Group Co Ltd, formerly Universal Medical Financial & Technical Advisory Services Co Ltd, is a company engaged in healthcare business. The Company mainly operates through two segments. The Finance Business segment mainly includes direct finance leasing, sale and leaseback, factoring, operating leases and advisory services. The Healthcare Business segment mainly includes healthcare services, hospital operation management and medical equipment import and export trade and domestic trade, equipment full cycle management and medical digital technology services. The Company mainly conducts business in China.
Directors
- Jiahong Peng CHM (50)
- Yan Zhao NEC (41)
- Wenbing Wang CEO (47)
- Jianying Chen DGM (38)
- Jingyao Yang DGM (48)
- Gang Yu EDR (55)
- Wai Kam Ng SEC
- Tong Chaoyin NED (56)
- Xiaopin Liu NED (59)
- Ziyang Zhu NED (26)
- Siu Lui Chow NID (61)
- Demin Han NID (70)
- Yinquan Li NID (66)
- Xinbo Liao NID (63)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- April 19th, 2012
- Public Since
- July 8th, 2015
- No. of Employees
- 21,521
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
Stock Exchange of Hong Kong Limited
- Shares in Issue
- 1,891,539,661

- Address
- 4th, 5th, 13th Floor, Hardmen Square, Bu, BEIJING
- Web
- https://www.umcare.cn/
- Phone
- Auditors
- Ernst & Young
Upcoming Events for 2666
Half Year 2025 Genertec Universal Medical Group Co Ltd Earnings Release
Similar to 2666
Adicon Holdings
Stock Exchange of Hong Kong Limited
Aidigong Maternal & Child Health
Stock Exchange of Hong Kong Limited
Arrail
Stock Exchange of Hong Kong Limited
Suzhou Basecare Medical
Stock Exchange of Hong Kong Limited
Beijing Health (Holdings)
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 23:52 UTC, shares in Genertec Universal Medical Co are trading at HK$4.91. This share price information is delayed by 15 minutes.
Shares in Genertec Universal Medical Co last closed at HK$4.91 and the price had moved by +4.91% over the past 365 days. In terms of relative price strength the Genertec Universal Medical Co share price has outperformed the FTSE Developed Asia Pacific Index by +6.11% over the past year.
The overall consensus recommendation for Genertec Universal Medical Co is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Genertec Universal Medical Co dividend yield is 7.13% based on the trailing twelve month period.
Last year, Genertec Universal Medical Co paid a total dividend of CNY0.33, and it currently has a trailing dividend yield of 7.13%. We do not have any data on when Genertec Universal Medical Co is to next pay dividends.
We do not have data on when Genertec Universal Medical Co is to next pay dividends. The historic dividend yield on Genertec Universal Medical Co shares is currently 7.13%.
To buy shares in Genertec Universal Medical Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$4.91, shares in Genertec Universal Medical Co had a market capitalisation of HK$9.29bn.
Here are the trading details for Genertec Universal Medical Co:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 2666
Based on an overall assessment of its quality, value and momentum Genertec Universal Medical Co is currently classified as a Turnaround. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Genertec Universal Medical Co is HK$7.70. That is 56.76% above the last closing price of HK$4.91.
Analysts covering Genertec Universal Medical Co currently have a consensus Earnings Per Share (EPS) forecast of CNY1.16 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Genertec Universal Medical Co. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +5.96%.
As of the last closing price of HK$4.91, shares in Genertec Universal Medical Co were trading +2.44% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Genertec Universal Medical Co PE ratio based on its reported earnings over the past 12 months is 3.9. The shares last closed at HK$4.91.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Genertec Universal Medical Co's management team is headed by:
- Jiahong Peng - CHM
- Yan Zhao - NEC
- Wenbing Wang - CEO
- Jianying Chen - DGM
- Jingyao Yang - DGM
- Gang Yu - EDR
- Wai Kam Ng - SEC
- Tong Chaoyin - NED
- Xiaopin Liu - NED
- Ziyang Zhu - NED
- Siu Lui Chow - NID
- Demin Han - NID
- Yinquan Li - NID
- Xinbo Liao - NID